首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survival
【24h】

Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survival

机译:绝对单核细胞计数将慢性淋巴细胞性白血病分为三类,分为免疫失调,疾病进展和生存不良的高危患者

获取原文
获取原文并翻译 | 示例
           

摘要

Peripheral absolute monocyte count (AMC) has been reported to correlate with clinical outcome in different types of cancers. This association may relate to alteration in circulating monocytic subpopulations and tumor infiltrating macrophages. In this study we evaluated the clinical significance of peripheral AMC in 80 treatment naive patients with CLL. Measurement of AMC was based on direct morphological enumeration, due to our findings that complete blood count data may yield incorrect monocytes enumeration values in CLL. The median AMC in patients with CLL was within normal limits, however the AMC range exceeded the values of healthy individuals. The AMC trichotomized patients into 3 distinct sub-groups with different characteristics and outcomes. High AMC patients were younger and had higher absolute lymphocytes count, while patients with low AMC had prominent immune dysregulation (lower serum IgA levels, susceptibility to infections and a tendency for positive direct anti-globulin test). The low and high AMC patients had a shorter time to treatment compared to the intermediates AMC subgroups, whereas low AMC was associated with increased mortality caused by infectious complications. In conclusion, AMC quantification during the disease course classifies CLL patients into subgroups with unique clinical features and outcomes.
机译:据报道,外周绝对单核细胞计数(AMC)与不同类型癌症的临床结果相关。这种关联可能与循环单核细胞亚群的改变和肿瘤浸润性巨噬细胞有关。在这项研究中,我们评估了80名未经治疗的CLL初治患者外周AMC的临床意义。由于我们发现全血细胞计数数据可能会在CLL中产生不正确的单核细胞计数值,因此AMC的测量基于直接的形态学计数。 CLL患者的AMC中值在正常范围内,但是AMC范围超出了健康个体的值。 AMC将患者分为三类,分别具有不同的特征和结局。高AMC患者较年轻且绝对淋巴细胞计数较高,而低AMC患者则具有明显的免疫失调(较低的血清IgA水平,易感染性和直接抗球蛋白检测阳性的趋势)。与中等水平的AMC亚组相比,低和高AMC患者的治疗时间更短,而低AMC与感染并发症导致的死亡率增加相关。总之,疾病过程中的AMC量化将CLL患者分为具有独特临床特征和结果的亚组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号